InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by MOMTAZEE JAMES C, Director. Officer active across 2 companies, notably PRA Health Sciences, Inc.. In total, 6 filings have been recorded. Total volume traded: €2.1m. The latest transaction was filed on 29 December 2021 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations6 total
€1m80,000 shares@ €12.81510.0069% mcap100.0% of flow
Common Stock
SEC:0000899243-22-000174·
Ideal exit: 25 Sept 2022 (T+270)
€1m80,000 shares@ €12.81510.0069% mcap50.0% of flow
Common Stock
SEC:0000899243-22-000174:0·
Ideal exit: 25 Sept 2022 (T+270)
3,521 shares
Common Stock
SEC:0001104659-21-088352·
3,521 shares
Common Stock
SEC:0001104659-21-088352:0·
0330 shares0
Common Stock
SEC:0001104659-21-076355·
0330 shares0
Common Stock
SEC:0001104659-21-076355:0·
6 of 6 declarations
About MOMTAZEE JAMES C
James C. Momtazee is a Board Member at PRA Health Sciences, Inc. and BridgeBio Pharma, Inc. He brings his expertise in corporate governance and strategy, contributing to the direction and decision-making within these organizations. His role is essential in ensuring compliance and performance.
